| Date Checked | 2025-12-21 23:37:20 |
|---|---|
| Graham Number | (PB)nan vs (PE)12.24 |
| Over / Under Value Percentage | 0.00% vs nan% |
| Dividend Yield | 0.00% |
| Dividend Date | 2019-05-10 |
| Symbol | NVAX |
| AssetType | Common Stock |
| Name | Novavax Inc |
| Description | Novavax, Inc. is a prominent biotechnology company headquartered in Gaithersburg, Maryland, specializing in the development of innovative vaccines for critical infectious diseases. Leveraging its proprietary protein-based nanoparticle technology, Novavax has positioned itself at the forefront of vaccine research, with its advanced COVID-19 vaccine candidate exemplifying its commitment to addressing urgent global health needs. The company's robust pipeline, combined with strategic partnerships and a focus on cutting-edge health solutions, highlights its potential for transformative impact in the healthcare sector, making it a compelling consideration for institutional investors seeking opportunities in biotechnology. |
| CIK | 1000694 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | BIOTECHNOLOGY |
| Address | 700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD, UNITED STATES, 20878 |
| OfficialSite | https://www.novavax.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 1082243000 |
| EBITDA | 451828000 |
| PERatio | 3.313 |
| PEGRatio | 0 |
| BookValue | -0.964 |
| DividendPerShare | None |
| EPS | 2.01 |
| RevenuePerShareTTM | 6.59 |
| ProfitMargin | 0.321 |
| OperatingMarginTTM | -1.127 |
| ReturnOnAssetsTTM | 0.18 |
| ReturnOnEquityTTM | -8.98 |
| RevenueTTM | 1064651000 |
| GrossProfitTTM | 632619000 |
| DilutedEPSTTM | 2.01 |
| QuarterlyEarningsGrowthYOY | -0.381 |
| QuarterlyRevenueGrowthYOY | -0.166 |
| AnalystTargetPrice | 12.67 |
| AnalystRatingStrongBuy | 1 |
| AnalystRatingBuy | 4 |
| AnalystRatingHold | 1 |
| AnalystRatingSell | 1 |
| AnalystRatingStrongSell | 2 |
| TrailingPE | 3.313 |
| ForwardPE | 2.585 |
| PriceToSalesRatioTTM | 1.016 |
| PriceToBookRatio | 41.23 |
| EVToRevenue | 0.539 |
| EVToEBITDA | 1.399 |
| Beta | 2.309 |
| 52WeekHigh | 11.55 |
| 52WeekLow | 5.01 |
| 50DayMovingAverage | 7.45 |
| 200DayMovingAverage | 7.38 |
| SharesOutstanding | 162499000 |
| SharesFloat | 134876000 |
| PercentInsiders | 8.751 |
| PercentInstitutions | 61.657 |
| ExDividendDate | None |
| naga | 1 |
| etoro | 1 |
| dateChecked | 2025-12-21 23:37:20 |
| fresh | 1 |